BG
GRCL

Bellevue Group’s Gracell Biotechnologies Inc. American Depositary Shares GRCL Stock Holding History

Bellevue Group’s Portfolio GRCL Stock Details GRCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-38,000
Closed -$109K – 177
2023
Q3 		$109K Sell
38,000
-107,646
-74% -$310K ﹤0.01% 147
2023
Q2 		$555K Buy
+145,646
New +$555K 0.01% 141